Log In
Print
BCIQ
Print
Print this Print this
 

Xamiol, calcipotriene/betamethasone dipropionate (Taclonex topical suspension)

Also known as: Taclonex Scalp (Taclonex Scalp gel) (LEO 80185)

  Manage Alerts
Collapse Summary General Information
Company Leo Pharma A/S
DescriptionTopical suspension containing 0.005% calcipotriene plus 0.064% betamethasone dipropionate
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of ActionGlucocorticoid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationPsoriasis
Indication DetailsTreat scalp and body psoriasis vulgaris
Regulatory Designation

Partner

Kyowa Hakko Kirin Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today